NCT03393702 is a Phase 4 clinical trial of Gabapentin in Pain, Postoperative, sponsored by National Institute for Tuberculosis and Lung Diseases, Poland.

Who is sponsoring NCT03393702?

NCT03393702 is sponsored by National Institute for Tuberculosis and Lung Diseases, Poland.

What drugs are being tested in NCT03393702?

Interventions in NCT03393702: Gabapentin, Placebo.

What condition does NCT03393702 study?

NCT03393702 studies Pain, Postoperative, Surgery, Thoracic.

Is NCT03393702 still recruiting?

NCT03393702 is currently completed. Last updated 8 September 2021.

Last reviewed 2021-09-08 · How we verify

NCT03393702

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin

Completed Phase 4 Last updated 8 September 2021

What this trial tests

Phase 4 trial testing Gabapentin in Pain, Postoperative in 104 participants. Completed in 3 December 2020.

Timeline

9 May 2017

Primary endpoint
30 December 2019

3 December 2020

Quick facts

Lead sponsor	National Institute for Tuberculosis and Lung Diseases, Poland
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	104
Start date	9 May 2017
Primary completion	30 December 2019
Estimated completion	3 December 2020
Sites	1 location across Poland

Drugs / interventions tested

Gabapentin (Gabapentin) — full drug profile →
Placebo

Conditions studied

Pain, Postoperative — all drugs for Pain, Postoperative →
Surgery, Thoracic — all drugs for Surgery, Thoracic →

Sponsor

National Institute for Tuberculosis and Lung Diseases, Poland

Who can join

Adults 5 to 18, any sex, with Pain, Postoperative or Surgery, Thoracic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is performed in patients aged 5-18 years after thoracic surgery. The primary aim of this trial is to determine whether the use of gabapentin as a component of multimodal analgesic regiments reduces pain scores following thoracic surgery in pediatric patients. The secondary objective of the trial are to evaluate whether the use of gabapentin reduces postoperative anxiety scores and consumption of ropivacaine with fentanyl, decreases side-effects, and improves patient satisfaction.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure-A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial.
Fenikowski D, Tomaszek L, Mazurek H, Gawron D, et al · · 2022 · cited 7× · PMID 36012932 · DOI 10.3390/jcm11164695
Factors Related to Anxiety in Paediatric Patients and Their Parents before and after a Modified Ravitch Procedure-A Single-Centre Cohort Study.
Fenikowski D, Tomaszek L. · · 2022 · cited 3× · PMID 36554581 · DOI 10.3390/ijerph192416701
Intravenous Morphine Infusion versus Thoracic Epidural Infusion of Ropivacaine with Fentanyl after the Ravitch Procedure-A Single-Center Cohort Study.
Fenikowski D, Tomaszek L. · · 2022 · cited 3× · PMID 36141560 · DOI 10.3390/ijerph191811291
Maximum Pain at Rest in Pediatric Patients Undergoing Elective Thoracic Surgery and the Predictors of Moderate-to-Severe Pain-Secondary Data Analysis.
Tomaszek L, Fenikowski D, Cież-Piekarczyk N, Mędrzycka-Dąbrowska W. · · 2024 · cited 2× · PMID 38337538 · DOI 10.3390/jcm13030844

Verify or expand the search:

Other trials of Gabapentin

Trials testing the same drug.

NCT07047040 — Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin · Phase 2, PHASE3 · not yet recruiting
NCT07131527 — Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy · NA · recruiting
NCT04613024 — Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty · EARLY_PHASE1 · withdrawn
NCT07389551 — Comparison of Pregabalin Versus Gabapentin as Pre-emptive Analgesic · NA · completed
NCT06992427 — High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Che · Phase 3 · recruiting

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting

Other National Institute for Tuberculosis and Lung Diseases, Poland trials

Trials by the same sponsor.

NCT05752708 — Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery · recruiting
NCT06964074 — PEP and O-PEP Device for Nebulization in Cystic Fibrosis · NA · active not recruiting
NCT04916834 — Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure. · unknown
NCT04036721 — Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis · Phase 4 · suspended
NCT04509921 — Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393702 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Institute for Tuberculosis and Lung Diseases, Poland
Last refreshed: 8 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing